Effect of adjunctive vitamin D supplementation as measured by serum vitamin D And NGF levels in Autism Spectrum Disorder
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: F840- Autistic disorder
- Registration Number
- CTRI/2023/08/057042
- Lead Sponsor
- Central Institute of Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Children diagnosed with autism spectrum disorder as per ICD11.
2.Childrenwith ASD who are drug naïve or drug free for 2 weeks.
3.Children of either gender up to 10 years of age.
Exclusion Criteria
1.Children with known genetic or neurological syndrome with an established link to Autism, history of epilepsy or current seizures, significant medical illness (endocrinopathies), pre-existing liver or kidney disease: sensory or motor impairment that would interfere with the valid completion of study measures.
2.Ongoing use of antiepileptics, steroids, immunosuppressants, bisphosphonates, calcium and vitamin supplements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method